SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-19-000887
Filing Date
2019-06-17
Accepted
2019-06-17 20:20:40
Documents
1
Period of Report
2019-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3779
  Complete submission text file 0001123292-19-000887.txt   5153
Mailing Address C/O OPTIMER PHARMACEUTICALS, INC 101 HUDSON STREET SAN DIEGO CA 07302
Business Address
Webster Stephen W (Reporting) CIK: 0001438421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38905 | Film No.: 19902478

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences